Sanofi SA reported a 9% increase in net sales to €34.5 billion for 2015 but its operating income slid by 7.3% to €5.6 billion because of a rise in all major expenses. The net sales figure excludes revenue from animal health products, which are set to be sold to Boehringer Ingelheim GmbH.
